Not a member yet? Register here
Health of Tomorrow
Art on View
Antithrombin and inherited deficiency: Current knowledge and perspectives
Index latest issue
Corrigendum to “Recent advances in targeted therapies for patients with acute myeloid leukemia”
Gene therapy for von Willebrand Disease
FLT3 inhibitors after allogeneic haematopoietic stem cell transplantation in paediatric AML
Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS syndrome) with multiple thromboembolism events: A Belgian case report
Heterophilic antibodies as the cause of a false positive malaria rapid diagnostic test: A case report
Highlights from the 20
New haematology reimbursements in Belgium
Future Directions in Platelet Research
Recent exposure to chemotherapy negatively impacts CAR-T cell treatment outcomes
Axicabtagene ciloleucel: potential new second-line standard of care for patients with relapsed...
Mosunetuzumab: effective and well-tolerated in the treatment of relapsed/refractory follicular...
Daratumumab plus VCd as a new standard of care for patients with newly diagnosed light-chain a...
Subcutaneous daratumumab plus pomalidomide-dexamethasone: an effective treatment option for M...
Dose-escalation of oral azacitidine provides clinical benefit to acute myeloid leukaemia patie...
Asciminib as a third line treatment for chronic phase chronic myeloid leukaemia